Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
In a regulatory filing, Grifols SA (NASDAQ:GRFS) said that Brookfield Capital has confirmed that it has engaged in preliminary discussions with Grifols's key shareholders regarding a potential joint offer to delist the company's shares from the Spanish stock exchanges and NASDAQ.
基立福SA(NASDAQ:GRFS)在一份監管文件中表示，Brookfield Capital已確認已與Grifols的主要股東進行初步討論，以就從西班牙證券交易所和納斯達克退市的公司股份進行可能的聯合報價。
Brookfield and the shareholders have signed an exclusivity agreement to explore this possibility further and requested access to certain company information to conduct due diligence.
Brookfield和股東已簽署排他性協議，以進一步探討這一可能性，並請求獲得某些公司信息以進行盡職調查。
Also Read: Spanish Healthcare Firm Grifols' Reputational Damage and Debt Woes: European Central Bank Probes Lenders.
閱讀更多：西班牙醫療保健公司Grifols的聲譽損害和債務問題：歐洲中央銀行調查貸方。
According to the information provided to the Board of Directors, Brookfield, and the Grifols family shareholders have agreed to evaluate a possible joint takeover bid to acquire Grifols.
根據向董事會提供的信息，Brookfield和Grifols家族股東已同意評估一項可能的聯合收購要約以收購Grifols。
The Board of Directors held an extraordinary meeting to allow access to certain company information to carry out a due diligence process regarding the intent of the transaction, in case The board goes through, would be delisting the company.
董事會召開了一次特別會議，允許訪問 certain company information 以進行盡職調查程序，此事項的意圖是退市公司。
Reuters noted that the founding family members own a 30% stake in Grifols.
路透社指出，Grifols創始家族成員持有該公司30%的股份。
In a regulatory filing, the Comisión Nacional del Mercado de Valores made the following decision: "Effective from 12:00 PM today, the precautionary suspension of Grifols has been lifted, applying to shares and related securities on the Stock Exchanges and Sistema de Interconexión Bursátil, Derivative contracts on these shares on MEFF Sociedad Rectora del Mercado de Productos Derivados, S.A.U., and Fixed Income Instruments issued on the CAPI OTF.
在一份監管文件中，Comisión Nacional del Mercado de Valores做出了以下決定："從今天下午12:00起，Grifols的預防性暫停已經解除，適用於證券交易所和Sistema de Interconexión Bursátil、MEFF Sociedad Rectora del Mercado de Productos Derivados、CAPI OTF發行的固收工具。"
Earlier, CNMV agreed to suspend the trading of Grifols shares.
CNMV早些時候同意暫停Grifols股票交易。
The suspension was lifted because sufficient information about the circumstances leading to the suspension has been made public to market operators and the CNMV."
之所以解除暫停，是因爲有關暫停的情況已經向市場運營商和CNMV公開披露。"
Citing business newspaper Cinco Dias, Reuters noted that the founding family aims to gain access to the company's books to make a final offer in the coming weeks.
援引商業報紙Cinco Dias，路透社指出，創始家族旨在獲取公司賬目，以在未來幾周內提出最終報價。
Reuters highlighted that the deal could be worth around 5.5 billion euros ($5.96 billion).
路透社強調，交易價值可能約爲55億歐元（596億美元）。
In March, Gotham City Research released a new report on Grifols questioning the company's "transparency, integrity and ethical conduct."
今年3月，Gotham City Research發佈了一份有關Grifols的新報告，質疑該公司的"透明度、誠信和道德行爲"。
Recently, Grifols appointed Rahul Srinivasan as the new Chief Financial Officer, effective September 16.
最近，Grifols任命Rahul Srinivasan爲新的首席財務官，任期自9月16日起生效。
Price Action: GRFS shares are up 20.90% at $8.51 at the last check on Monday.
股票價格： GRFS股票在週一最後交易時上漲20.90美元至8.51美元。
- Grifols Gets Downgraded: Fitch, S&P Flag Cash Flow Concerns At Pharma Company.
- 格里福斯（Grifols）股票下調：Fitch，S&P標註藥品公司現金流擔憂。
Photo via Wikimedia Commons
照片通過Wikimedia Commons
譯文內容由第三人軟體翻譯。